Effect of Ginseng on Glycemic Control
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01841229 |
Recruitment Status : Unknown
Verified May 2013 by Unity Health Toronto.
Recruitment status was: Active, not recruiting
First Posted : April 26, 2013
Last Update Posted : May 23, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Impaired Glucose Tolerance Diabetes |
Study Type : | Observational |
Actual Enrollment : | 770 participants |
Official Title: | Effect of Ginseng on Glycemic Control: A Systematic Review and Meta-analysis of Controlled Trials to Provide Evidence-based Clinical Recommendations |
Study Start Date : | October 2012 |
Estimated Primary Completion Date : | May 2013 |
Estimated Study Completion Date : | May 2013 |
- Glycated hemoglobin (HbA1c) [ Time Frame: 1month ]
- Fasting blood glucose [ Time Frame: 1month ]
- Fasting plasma insulin [ Time Frame: 1 month ]
- Homeostasis model assessment of insulin resistance (HOMA-IR) [ Time Frame: 1 month ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Dietary trials in humans
- Randomized treatment allocation
- 1 month
- Suitable control
- Viable endpoint data
Exclusion Criteria:
- Non-human studies
- Non-randomized treatment allocation
- <1 month
- Lack of a suitable control
- No viable endpoint data

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01841229
Canada, Ontario | |
The Toronto 3D Knowledge Synthesis and Clinical trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St.Michael's Hospital. | |
Toronto, Ontario, Canada, M5C 2T2 |
Principal Investigator: | Vladimir Vuksan, PhD | Unity Health Toronto |
Responsible Party: | Unity Health Toronto |
ClinicalTrials.gov Identifier: | NCT01841229 |
Other Study ID Numbers: |
MetaG |
First Posted: | April 26, 2013 Key Record Dates |
Last Update Posted: | May 23, 2013 |
Last Verified: | May 2013 |
Glucose Intolerance Hyperglycemia Glucose Metabolism Disorders Metabolic Diseases |